HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nan Chiang Selected Research

Lipoxins

1/2019Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions.
12/2017Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.
1/2016Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
9/2015The Regulation of Proresolving Lipid Mediator Profiles in Baboon Pneumonia by Inhaled Carbon Monoxide.
5/2015The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
10/2009Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.
5/2008Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.
4/2008Anesthetics impact the resolution of inflammation.
2/2004Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
5/2003A novel rat lipoxin A4 receptor that is conserved in structure and function.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nan Chiang Research Topics

Disease

41Inflammation (Inflammations)
01/2021 - 01/2002
8Infections
01/2021 - 04/2012
6Peritonitis
01/2013 - 05/2003
2Ischemia
11/2014 - 10/2003
2Cardiovascular Diseases (Cardiovascular Disease)
03/2005 - 02/2004
1Pain (Aches)
12/2017
1Hypothermia
01/2017
1Sepsis (Septicemia)
01/2017
1Staphylococcal Infections
01/2016
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2016
1Thrombosis (Thrombus)
01/2016
1Aggressive Periodontitis (Periodontosis)
12/2015
1Bacterial Pneumonia
09/2015
1Pneumonia (Pneumonitis)
09/2015
1Bacterial Infections (Bacterial Infection)
09/2015
1Reperfusion Injury
05/2015
1Acute Lung Injury
11/2014
1Animal Disease Models
08/2013
1Alveolar Bone Loss
01/2013
1Escherichia coli Infections
04/2012
1Corneal Neovascularization
10/2009
1Muscle Cramp (Cramp)
04/2008
1Neoplasms (Cancer)
02/2004
1Stroke (Strokes)
10/2003
1Brain Ischemia (Cerebral Ischemia)
10/2003
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2003

Drug/Important Bio-Agent (IBA)

19LipidsIBA
01/2018 - 01/2002
11LipoxinsIBA
01/2019 - 01/2002
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2013 - 01/2002
5ProstaglandinsIBA
01/2018 - 11/2011
5Eicosapentaenoic AcidIBA
09/2015 - 03/2005
55S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA
01/2013 - 03/2005
4EicosanoidsIBA
01/2018 - 05/2008
4LeukotrienesIBA
01/2018 - 11/2011
4MicroRNAs (MicroRNA)IBA
11/2013 - 02/2011
4ZymosanIBA
01/2013 - 06/2007
37,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA
12/2019 - 12/2015
3Biological ProductsIBA
11/2019 - 01/2018
3Carbon MonoxideIBA
09/2015 - 06/2013
3Fatty Acids (Saturated Fatty Acids)IBA
01/2013 - 10/2003
2resolvin D2IBA
01/2017 - 07/2015
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2016 - 02/2013
2resolvin D1IBA
11/2014 - 05/2012
2Proteins (Proteins, Gene)FDA Link
04/2008 - 05/2003
2AutacoidsIBA
09/2005 - 02/2004
2lipoxin A4IBA
02/2004 - 01/2002
1CD59 AntigensIBA
01/2021
1TNF Receptor-Associated Factor 3IBA
01/2021
1Arachidonic Acid (Vitamin F)IBA
12/2017
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2017
1resolvin D4IBA
01/2016
1OmacorFDA Link
01/2016
1Leukotriene B4IBA
09/2015
1Atorvastatin (Lipitor)FDA Link
09/2015
1Heme Oxygenase-1IBA
06/2013
1Interleukin-10 (Interleukin 10)IBA
05/2012
1Ciprofloxacin (Cipro)FDA LinkGeneric
04/2012
1VancomycinFDA LinkGeneric
04/2012
1Anti-Bacterial Agents (Antibiotics)IBA
04/2012
1ThromboxanesIBA
11/2011
1Pharmaceutical PreparationsIBA
01/2011
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2009
1Anesthetics (Anesthetic Agents)IBA
04/2008
1Interleukin-4 (Interleukin 4)IBA
04/2008
1CytokinesIBA
04/2008
1ChemokinesIBA
04/2008
1Lidocaine (Xylocaine)FDA LinkGeneric
04/2008
1Cofilin 1IBA
04/2008
1IsofluraneFDA LinkGeneric
04/2008
1Peptides (Polypeptides)IBA
04/2008
1Galectin 1 (LGALS1)IBA
04/2008
1Interleukin-13IBA
04/2008
1Local AnestheticsIBA
04/2008
1protectin D1IBA
06/2007
1Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA
03/2007
1Fish OilsIBA
03/2005
1Interleukin-12 (IL 12)IBA
03/2005
1InterleukinsIBA
03/2005
1Docosahexaenoic AcidsIBA
10/2003
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2003
1Lipid PeroxidesIBA
10/2003
1Phospholipids (Phosphatides)FDA LinkGeneric
10/2003
1Caseins (Casein)FDA Link
05/2003
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2002
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2002

Therapy/Procedure

5Therapeutics
12/2015 - 02/2004
2Ligation
01/2017 - 01/2013
1Punctures
01/2017
1Critical Care (Surgical Intensive Care)
11/2014
1Sutures (Suture)
10/2009